IP Library Granted Patent US 6,903,113
Granted Patent B2
US 6,903,113 · App. 10/771,639 · Granted Jun 7, 2005

Urea substituted imidazopyridines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,903,113
App. No.
10/771,639
Granted
Jun 7, 2005
Kind
B2
Abstract

Imidazopyridine compounds that contain urea or thiourea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Claims (33)

1. A compound of the formula (I):

wherein

X is C 1-10 alkylene;

Y is —CO—;

Z is —NR 6 —;

R 1 is C 1-10 alkyl wherein alkyl is straight chain alkyl, branched chain alkyl, or cycloalkyl;

R 2 is selected from the group consisting of:

C 1-4 alkyl,

ethoxymethyl, and

methoxyethyl;

R 3 and R 4 are methyl;

R 5 is hydrogen; and

R 6 is hydrogen;

or a pharmaceutically acceptable salt thereof.

2. The compound or salt of claim 1 wherein R 1 is cyclohexyl, and R 2 is ethoxymethyl.

3. The compound or salt of claim 1 wherein R 1 is C 1-6 alkyl.

4. The compound or salt of claim 1 wherein R 1 is C 1-4 alkyl.

5. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 1 in combination with a pharmaceutically acceptable carrier.

6. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 2 in combination with a pharmaceutically acceptable carrier.

7. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 3 in combination with a pharmaceutically acceptable carrier.

8. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt of claim 4 in combination with a pharmaceutically acceptable carrier.

9. A method of inducing cytokine biosynthesis in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 1 to the animal.

10. A method of treating a viral disease in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 1 to the animal.

11. A method of treating a neoplastic disease in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 1 to the animal.

12. A method of inducing cytokine biosynthesis in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 2 to the animal.

13. A method of treating a viral disease in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 2 to the animal.

14. A method of treating a neoplastic disease in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 2 to the animal.

15. A method of inducing cytokine biosynthesis in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 3 to the animal.

16. A method of treating a viral disease in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 3 to the animal.

17. A method of treating a neoplastic disease in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 3 to the animal.

18. A method of inducing cytokine biosynthesis in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 4 to the animal.

19. A method of treating a viral disease in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 4 to the animal.

20. A method of treating a neoplastic disease in an animal comprising administering a therapeutically effective amount of a compound or salt of claim 4 to the animal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2007
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: COLEY PHARMACEUTICAL GROUP, INC.
Reel/Frame 019965/0551 →